{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:52:58Z","timestamp":1774446778697,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,23]]},"group-title":"Psychiatry and Clinical Psychology","reference-count":40,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Tobacco and cannabis are the most used substances among individuals at clinical high risk for psychosis (CHR-P), but it remains controversial whether substance use drives symptom exacerbation and psychosis transition, or vice versa. We investigated longitudinal dose-response relationships of tobacco and cannabis use with clinical presentation in a CHR-P population.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data was obtained from the North American Prodrome Longitudinal Study (NAPLS2) CHR-P cohort (n=764). Participants were assessed every 6 months over two years. Substance use frequency, psychiatric symptoms (psychosis, depression, anxiety, and social anxiety), global social and role functioning, and neurocognitive performance were measured. Linear mixed effect models were used to model the relationship between substance use and clinical measurements across visits, and that between baseline use and trajectory of symptoms, functioning, and cognition.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Psychiatric symptoms, functioning, and cognitive performance improved, while tobacco and cannabis use frequency did not change over two years for CHR-P individuals in NAPLS2. Heavier tobacco and cannabis use at current visit predicted worse anxiety at next visit (tobacco: \u03b2=0.178, p=0.033; cannabis: \u03b2=0.162, p=0.018). Better social functioning predicted heavier tobacco (\u03b2=0.178, p&lt;0.001) and cannabis: (\u03b2=0.162, p&lt;0.001) use at next visit. We observed a significant baseline cannabis-by-time interaction, where heavier baseline cannabis use predicted slower improvement of negative symptoms (\u03b2=0.159, p=0.0017, FDRp=0.0067) and deterioration of role function (\u03b2=-0.046, p=0.018).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In CHR-R, current tobacco and cannabis use predicted worse anxiety at future visits. Baseline cannabis use frequency predicts worse clinical trajectory, especially for negative symptoms.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.03.16.26347411","type":"posted-content","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:00:25Z","timestamp":1774288825000},"source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Relationships Between Cannabis and Tobacco Use and Symptom Severity in Individuals at Clinical High Risk for Psychosis"],"prefix":"10.64898","author":[{"given":"Yunong","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Vandekar","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandee","family":"Feola","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-923X","authenticated-orcid":false,"given":"Carrie E.","family":"Bearden","sequence":"additional","affiliation":[{"name":"Semel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Behavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Cadenhead","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyrone D.","family":"Cannon","sequence":"additional","affiliation":[{"name":"Department of Psychology and Psychiatry, Yale University, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cornblatt","sequence":"additional","affiliation":[{"name":"Institute for Behavioral Science, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, USA"},{"name":"Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matcheri","family":"Keshavan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Mathalon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Veterans Affairs San Francisco Health Care System, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana O.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Seidman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming T.","family":"Tsuang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine F.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Psychology, Emory University, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-5228","authenticated-orcid":false,"given":"Scott","family":"Woods","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale University, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo E","family":"Carri\u00f3n","sequence":"additional","affiliation":[{"name":"Institute for Behavioral Science, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, USA"},{"name":"Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Burrell","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026032505000975000_2026.03.16.26347411v1.1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S210199"},{"issue":"5","key":"2026032505000975000_2026.03.16.26347411v1.2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00127-019-01810-x","article-title":"Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review","volume":"55","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"8","key":"2026032505000975000_2026.03.16.26347411v1.3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S2215-0366(15)00152-2","article-title":"Does tobacco use cause psychosis? Systematic review and meta-analysis","volume":"2","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"2026032505000975000_2026.03.16.26347411v1.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15010126"},{"key":"2026032505000975000_2026.03.16.26347411v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003"},{"key":"2026032505000975000_2026.03.16.26347411v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20341"},{"issue":"1","key":"2026032505000975000_2026.03.16.26347411v1.7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026032505000975000_2026.03.16.26347411v1.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09030311"},{"issue":"1","key":"2026032505000975000_2026.03.16.26347411v1.9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41537-022-00218-y","article-title":"Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis","volume":"8","year":"2022","journal-title":"Schizophrenia"},{"key":"2026032505000975000_2026.03.16.26347411v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.04.021"},{"issue":"5","key":"2026032505000975000_2026.03.16.26347411v1.11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/eip.12751","article-title":"Tobacco use and psychosis risk in persons at clinical high risk","volume":"13","year":"2019","journal-title":"Early Interv Psychiatry"},{"issue":"3","key":"2026032505000975000_2026.03.16.26347411v1.12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/eip.12112","article-title":"Reasons for cannabis use among youths at ultra high risk for psychosis","volume":"9","year":"2015","journal-title":"Early Interv Psychiatry"},{"key":"2026032505000975000_2026.03.16.26347411v1.13","doi-asserted-by":"publisher","DOI":"10.3109\/00048671003689710"},{"key":"2026032505000975000_2026.03.16.26347411v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.347"},{"key":"2026032505000975000_2026.03.16.26347411v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.03.015"},{"key":"2026032505000975000_2026.03.16.26347411v1.16","unstructured":"Winton-Brown T , Kumari V , Windler F , Moscoso A , Stone J , Kapur S , et al. Sensory gating, cannabis use and the risk of psychosis. Early Interv Psychiatry. 2014;"},{"issue":"12","key":"2026032505000975000_2026.03.16.26347411v1.17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamapsychiatry.2016.2479","article-title":"Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study","volume":"73","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2026032505000975000_2026.03.16.26347411v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/SCHBUL\/SBY126"},{"key":"2026032505000975000_2026.03.16.26347411v1.19","doi-asserted-by":"crossref","first-page":"1075222","DOI":"10.3389\/fpsyt.2022.1075222","article-title":"Cognitive functioning in a group of adolescents at risk for psychosis","volume":"13","year":"2022","journal-title":"Front Psychiatry"},{"key":"2026032505000975000_2026.03.16.26347411v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.07.085"},{"key":"2026032505000975000_2026.03.16.26347411v1.21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.schres.2024.07.032","article-title":"Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts","volume":"271","year":"2024","journal-title":"Schizophr Res"},{"key":"2026032505000975000_2026.03.16.26347411v1.22","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715001646"},{"key":"2026032505000975000_2026.03.16.26347411v1.23","unstructured":"McGlashan T , Walsh B , Woods S . The Psychosis-Risk Syndrome. 1st ed. Oxford University Press; 2010."},{"key":"2026032505000975000_2026.03.16.26347411v1.24","unstructured":"Drake R , Mueser K , McHugo G. Clinician rating scales: Alcohol use scale (AUS), drug use scale (DUS), and substance abuse treatment scale (SATS). In: Outcome Assessment in Clinical Practice. 1st ed. Williams and Wilkins; 1996. p. 113\u20136."},{"key":"2026032505000975000_2026.03.16.26347411v1.25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.12.6.371"},{"key":"2026032505000975000_2026.03.16.26347411v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(97)10031-6"},{"key":"2026032505000975000_2026.03.16.26347411v1.27","first-page":"39","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","volume":"22","year":"1993","journal-title":"Br J Psychiatry Suppl"},{"key":"2026032505000975000_2026.03.16.26347411v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.09.006"},{"key":"2026032505000975000_2026.03.16.26347411v1.29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07010042"},{"key":"2026032505000975000_2026.03.16.26347411v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.09.010"},{"key":"2026032505000975000_2026.03.16.26347411v1.31","doi-asserted-by":"crossref","unstructured":"Feola B , Jenkins M , Sheffield JM , Blackford JU. Fear and Anxiety in Schizophrenia: A Focus on Development, Assessment, and Mechanisms. In: Blackford JU , Milad MR , editors. New Discoveries in the Brain Sciences of Fear and Anxiety - From Basic to Clinical Neuroscience [Internet]. Cham: Springer Nature Switzerland; 2024 [cited 2025 Dec 3]. p. 581\u2013607. (Current Topics in Behavioral Neurosciences; vol. 73). Available from: https:\/\/link.springer.com\/10.1007\/7854_2024_558","DOI":"10.1007\/7854_2024_558"},{"key":"2026032505000975000_2026.03.16.26347411v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.03.024"},{"issue":"5","key":"2026032505000975000_2026.03.16.26347411v1.33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpsychires.2012.02.011","article-title":"Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample","volume":"46","year":"2012","journal-title":"J Psychiatr Res"},{"key":"2026032505000975000_2026.03.16.26347411v1.34","doi-asserted-by":"crossref","first-page":"115420","DOI":"10.1016\/j.psychres.2023.115420","article-title":"Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns","volume":"328","year":"2023","journal-title":"Psychiatry Res"},{"key":"2026032505000975000_2026.03.16.26347411v1.35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.schres.2018.08.035","article-title":"Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning","volume":"204","year":"2019","journal-title":"Schizophr Res"},{"key":"2026032505000975000_2026.03.16.26347411v1.36","doi-asserted-by":"crossref","unstructured":"Kuhney FS , Damme KSF , Pelletier-Baldelli A , Chun C , Ellman LM , Schiffman J , et al. Prevalence and Functional Consequences of Social Anxiety in Individuals at Clinical High-Risk for Psychosis: Perspective From a Community Sample Comparison. Schizophr Bull Open. 2021 Jan 1;2(1):sgab025.","DOI":"10.1093\/schizbullopen\/sgab025"},{"issue":"8","key":"2026032505000975000_2026.03.16.26347411v1.37","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1017\/S0033291722000277","article-title":"Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes","volume":"53","year":"2023","journal-title":"Psychol Med"},{"key":"2026032505000975000_2026.03.16.26347411v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.03.040"},{"issue":"1\u20133","key":"2026032505000975000_2026.03.16.26347411v1.39","first-page":"204","article-title":"Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis","volume":"169","year":"2015","journal-title":"Schizophr Res"},{"key":"2026032505000975000_2026.03.16.26347411v1.40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0167-2231(85)90035-1","article-title":"Vector autoregressions for causal inference?","volume":"22","year":"1985","journal-title":"Carnegie-Rochester Conf Ser Public Policy"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.16.26347411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:00:23Z","timestamp":1774440023000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.03.16.26347411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":40,"URL":"https:\/\/doi.org\/10.64898\/2026.03.16.26347411","relation":{},"subject":[],"published":{"date-parts":[[2026,3,23]]},"subtype":"preprint"}}